BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28622344)

  • 1. Protecting an island nation from extreme pandemic threats: Proof-of-concept around border closure as an intervention.
    Boyd M; Baker MG; Mansoor OD; Kvizhinadze G; Wilson N
    PLoS One; 2017; 12(6):e0178732. PubMed ID: 28622344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of border closure for a generic severe pandemic threat using New Zealand Treasury methods.
    Boyd M; Mansoor OD; Baker MG; Wilson N
    Aust N Z J Public Health; 2018 Oct; 42(5):444-446. PubMed ID: 30088691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influenza pandemic of 1918-1919 in two remote island nations: Iceland and New Zealand.
    Summers JA; Wilson N; Baker MG; Gottfredsson M
    N Z Med J; 2013 Apr; 126(1373):74-80. PubMed ID: 23797079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of preemptive school closures to mitigate pandemic influenza outbreaks of differing severity in the United States.
    Dauelsberg LR; Maskery B; Joo H; Germann TC; Del Valle SY; Uzicanin A
    BMC Public Health; 2024 Jan; 24(1):200. PubMed ID: 38233845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A national estimate of the hospitalisation costs for the influenza (H1N1) pandemic in 2009.
    Wilson N; Nhung N; Higgins A; Kvizhinadze G; Baker MG; Blakely T
    N Z Med J; 2012 Nov; 125(1365):16-20. PubMed ID: 23254496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Border control measures in the influenza pandemic plans of six South Pacific nations: a critical review.
    McLeod M; Kelly H; Wilson N; Baker MG
    N Z Med J; 2008 Jul; 121(1278):62-72. PubMed ID: 18670475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2009 influenza pandemic: a review of the strengths and weaknesses of the health sector response in New Zealand.
    Wilson N; Summers JA; Baker MG
    N Z Med J; 2012 Nov; 125(1365):54-66. PubMed ID: 23254501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possible macroeconomic impact on the UK of an influenza pandemic.
    Keogh-Brown MR; Wren-Lewis S; Edmunds WJ; Beutels P; Smith RD
    Health Econ; 2010 Nov; 19(11):1345-60. PubMed ID: 19816886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health outcomes and costs of community mitigation strategies for an influenza pandemic in the United States.
    Perlroth DJ; Glass RJ; Davey VJ; Cannon D; Garber AM; Owens DK
    Clin Infect Dis; 2010 Jan; 50(2):165-74. PubMed ID: 20021259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of the vaccination program against seasonal and pandemic A/H1N1 influenza among customs officers in Greece.
    Mamma M; Spandidos DA
    Health Policy; 2013 Jan; 109(1):71-7. PubMed ID: 23195436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the content of the New Zealand influenza pandemic plan with European pandemic plans.
    Wilson N; Baker MG
    N Z Med J; 2009 Feb; 122(1290):36-46. PubMed ID: 19319167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prioritization of Island Nations as Refuges from Extreme Pandemics.
    Boyd M; Wilson N
    Risk Anal; 2020 Feb; 40(2):227-239. PubMed ID: 31546285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Zealand's experience of the 1918-19 influenza pandemic: a systematic review after 100 years.
    Summers JA; Baker M; Wilson N
    N Z Med J; 2018 Dec; 131(1487):54-69. PubMed ID: 30543612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories.
    Kelso JK; Halder N; Postma MJ; Milne GJ
    BMC Public Health; 2013 Mar; 13():211. PubMed ID: 23496898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical interventions for mitigating an influenza pandemic: modeling the risks and health-economic impacts.
    Postma MJ; Milne G; Nelson EA; Pyenson B; Basili M; Coker R; Oxford J; Garrison LP;
    Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1431-9. PubMed ID: 21133667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic burden of the 2009 pandemic H1N1 influenza in Korea.
    Kim YW; Yoon SJ; Oh IH
    Scand J Infect Dis; 2013 May; 45(5):390-6. PubMed ID: 23240778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the economic impact of pandemic influenza: An application of the computable general equilibrium model to the U.K.
    Smith RD; Keogh-Brown MR; Barnett T
    Soc Sci Med; 2011 Jul; 73(2):235-44. PubMed ID: 21708419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Border closure for island nations? Analysis of pandemic and bioweapon-related threats suggests some scenarios warrant drastic action.
    Boyd M; Baker MG; Wilson N
    Aust N Z J Public Health; 2020 Apr; 44(2):89-91. PubMed ID: 32259383
    [No Abstract]   [Full Text] [Related]  

  • 20. Mitigation of pandemic influenza: review of cost-effectiveness studies.
    Lugnér AK; Postma MJ
    Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):547-58. PubMed ID: 19941432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.